ACET Q2 2022 Earnings — Adicet Bio, Inc. Revenue & Financial Results | Market Cap Arena

ACETAdicet Bio, Inc.

$71M

Q2 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

$0

Operating Income

-$23M

Net Income

-$23M

EPS (Diluted)

$-8.96

QoQ Revenue Growth

-100.0%

Cash Flow

Operating Cash Flow

-$15M

Free Cash Flow

-$18M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$330M

Total Liabilities

$37M

Stockholders' Equity

$293M

Cash & Equivalents

$261M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$5M	-100.0%
Gross Profit	$0	$5M	-100.0%
Operating Income	-$23M	-$11M	-109.7%
Net Income	-$23M	-$11M	-107.6%